See the DrugPatentWatch profile for Quizartinib
How much does quizartinib cost (and what price should you use)?
There isn’t enough reliable, up-to-date pricing information in the provided material to give a specific quizartinib price. Drug pricing can vary a lot by country, payer (private insurance vs. national health system), dose, treatment schedule, and whether the product is branded or supplied through a manufacturer/program.
Does quizartinib have different prices by country or access program?
Yes—pricing for cancer medicines like quizartinib typically differs by jurisdiction and access pathway (for example, list price vs. negotiated payer prices, hospital/contract pricing, or pricing tied to clinical trial supply). Without the country and the source you want (retail pharmacy, hospital acquisition, or payer rate), a single number would likely be misleading.
What information do I need to quote a real quizartinib price?
If you share:
1) your country (and currency), and
2) whether you want the “list price,” “insured/copay,” or “manufacturer/hospital price,” and
3) the formulation and dose you’re looking at,
I can help you pinpoint the right kind of price target.
Are there alternatives if the price is too high?
If cost is the concern, the practical options usually depend on eligibility: patient assistance programs, clinical trials, or therapeutic alternatives in the same disease setting. The best route depends on your location and indication.